Eli Lilly and Company
9 mentions across Convex research, last mentioned
Recent Analysis Mentioning Eli Lilly and Company
Gold traded near $4,700 in mid-May 2026 even after the inflation shock of 2022 faded and real yields stayed positive. The clean explanation is not a resurrected CPI trade. It is a reserve-allocation trade: central banks bought more than 1,000 tonnes a year from 2022 through 2024 and another 863 tonnes in 2025, changing who sets the marginal price.
macroMarkets are pricing a fragile truce; the data says the risk premium is still too thin
GeopoliticsA strait that reopens under threat of re-closure is not a strait that's open, markets will price that distinction Monday.
GeopoliticsMarkets are frozen at Friday's close, the repricing queue is building in silence.
EnergyFrom Brazil's rare earth gambit to the Warsh hearing, the signal density is unusually high.
MacroSemiconductor demand is structurally intact, the question is whether stagflation absorbs the upside.
EquityA supply shock reversal hits an already-crowded short oil book, but stagflation's inflation pillar takes a real hit.
EnergyGeopolitical relief clears one tail risk but does nothing for the CPI-stagflation nexus closing in on April 10.
GeopoliticsMilitary action on nuclear facilities removes the ceasefire escape valve from our framework at the worst macro moment.
GeopoliticsMetrics Affected By Eli Lilly and Company
Related Topics
Get new analysis on Eli Lilly and Company and related topics delivered to your inbox.
Topic hubs aggregate extracted entity mentions from Convex research with related metrics, scenarios, and relationships. Information is for research purposes only and does not constitute financial advice.